Support independent, student-run journalism.

Your support helps give staff members from all backgrounds the opportunity to conduct meaningful reporting on important issues at Stanford. All contributions are tax-deductible.

Vaden responds to birth control pill recall

No Stanford-bound medicine was included in the about 1 million packs of birth control pills voluntarily recalled by drug manufacturer Pfizer on Jan. 31 due to incorrect packaging, said a Stanford health administrator. While Vaden Health Center at Stanford does not carry any of the affected medication, campus Peer Health Educators (PHE) have been briefed on how to handle the recall, wrote Robyn Tepper, director of medical services at Vaden, in an email to The Daily.